Literature DB >> 15251355

Liver transplant for the septuagenarians: importance of patient selection.

K Safdar1, G W Neff, M Montalbano, D Meyer, C O'Brien, N Yamashiki, E Schiff, A Tzakis.   

Abstract

With the increasing success of liver transplantation (OLT), more patients above 70 years of age are being considered for OLT. There is not enough data about the predictors for survival in this patient population. We retrospectively analyzed the medical records of 33 patients at least 70 years of age who received 34 OLT from July 1995 to July 2002. There were 16 women and 17 men of mean age 73.7 years. Etiologies of end-stage liver disease (ESLD) were: HCV (17/33, 52%), cryptogenic cirrhosis (8/33, 24%), PBC (3/33, 9%), Laennec's cirrhosis (2/33, 6%), and others (3/33, 9%). According to the UNOS classification, 15/34 (44%) were status 3, 16/34 (47%) status 2, and 3/34 (9%) status 1. Among 13/33 patients who died (39%), 1-year and 3-year survival rates were 78.79% and 71.43%, respectively. Based on UNOS criteria, 4/15 (26%) were status 3; 6/16 (37%), status 2; and 3/3 (100%), status 1 (P value = .04 for status 1 patients). There was no statistical differences between the scores using the Model for End-Stage Liver Disease (MELD) among those who died (MELD (19) versus MELD (17.35) respectively (P = .50). There was a statistically significant difference in cold ischemia time (CIT) and warm ischemia time (WIT) between those who died (P = .024 and.010, respectively). These results suggest that in this group of patients UNOS status classification, CIT and WIT correlate with survival. The sample size was too small to derive a conclusion about the association with the MELD score. Copyright 2004 Elsevier Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15251355     DOI: 10.1016/j.transproceed.2004.04.086

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  5 in total

1.  Outcomes among older adult liver transplantation recipients in the model of end stage liver disease (MELD) era.

Authors:  Maricar F Malinis; Shu Chen; Heather G Allore; Vincent J Quagliarello
Journal:  Ann Transplant       Date:  2014-09-26       Impact factor: 1.530

2.  Outcomes after liver transplant in patients aged 70 years or older compared with those younger than 60 years.

Authors:  Javier F Aduen; Bangarulingam Sujay; Rolland C Dickson; Michael G Heckman; Winston R Hewitt; Wolf H Stapelfeldt; Jeffrey L Steers; Denise M Harnois; David J Kramer
Journal:  Mayo Clin Proc       Date:  2009-11       Impact factor: 7.616

Review 3.  Liver transplantation in elderly patients: what do we know at the beginning of 2020?

Authors:  Shimon Dolnikov; René Adam; Daniel Cherqui; Marc Antoine Allard
Journal:  Surg Today       Date:  2020-04-11       Impact factor: 2.549

4.  Recipient Age and Mortality After Liver Transplantation: A Population-based Cohort Study.

Authors:  Eunmi Gil; Jong Man Kim; Kyeongman Jeon; Hyejeong Park; Danbee Kang; Juhee Cho; Gee Young Suh; Jinkyeong Park
Journal:  Transplantation       Date:  2018-12       Impact factor: 4.939

Review 5.  Transplant of Elderly Patients: Is There an Upper Age Cutoff?

Authors:  Claudia Cottone; Nathalie A Pena Polanco; Kalyan Ram Bhamidimarri
Journal:  Clin Liver Dis       Date:  2020-10-21       Impact factor: 6.126

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.